An Inpatient Advance Care Planning Intervention for Older Patients With Hematologic Malignancies

Completed · Not applicable

Conditions studied: Hematologic Malignancies

In brief

This is a pilot study to assess the preliminary efficacy of an inpatient advance care planning intervention on outcomes in older patients with hematologic malignancies

Key facts

Study ID

NCT05433090

Run by

University of Rochester

People needed

41

Starts

2022-11-23

Expected to finish

2024-11-14

Last updated by the study team

2026-03-31

Who can join

Age: 60 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age ≥60 years
• A diagnosis of hematologic malignancy [including but not limited to acute leukemia, myeloid malignancies (e.g., atypical CML, MDS/MPN overlap syndromes, CMML), multiple myeloma, lymphoma, or any other hematologic malignancies based on the primary oncologist's judgment]
• Able to provide informed consent
• Being managed in the inpatient setting
• English-speaking

You may not qualify if…

• None

Where it is running

• University of Rochester — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.